125 related articles for article (PubMed ID: 2181939)
1. [DNA damage and anticancer effect].
Kanamaru R; Ishioka C; Konishi Y; Ishikawa S; Shibata H; Wakui A
Gan To Kagaku Ryoho; 1990 Mar; 17(3 Pt 2):517-23. PubMed ID: 2181939
[TBL] [Abstract][Full Text] [Related]
2. Damage to DNA strand and the effects of anticancer drugs.
Kanamaru R; Ishioka C; Konishi Y; Ishikawa A; Shibata H; Wakui A
Sci Rep Res Inst Tohoku Univ Med; 1989 Dec; 36(1-4):29-36. PubMed ID: 2640065
[TBL] [Abstract][Full Text] [Related]
3. [Analysis of DNA damage induced by nitrosourea derivatives in rat brain tumor cells using a sequencing procedure].
Mineura K; Fushimi S; Sasajima H; Sasaki J; Ishino Y; Kowada M
Gan To Kagaku Ryoho; 1988 Feb; 15(2):307-11. PubMed ID: 3422552
[TBL] [Abstract][Full Text] [Related]
4. DNA damage induced by a new 2-chloroethyl nitrosourea on malignant melanoma cells.
Godeneche D; Rapp M; Thierry A; Laval F; Madelmont JC; Chollet P; Veyre A
Cancer Res; 1990 Sep; 50(18):5898-903. PubMed ID: 2393861
[TBL] [Abstract][Full Text] [Related]
5. Cytotoxicity and DNA damaging effects of a new nitrosourea, fotemustine, diethyl- 1-(3-(2-chloroethyl)-3-nitrosoureido) ethylphosphonate-S10036.
Tapiero H; Yin MB; Catalin J; Paraire M; Deloffre P; Rustum Y; Bizzari JP; Tew KD
Anticancer Res; 1989; 9(6):1617-22. PubMed ID: 2627116
[TBL] [Abstract][Full Text] [Related]
6. In vitro evaluation of the new anticancer agents KT6149, MX-2, SM5887, menogaril, and liblomycin using cisplatin- or adriamycin-resistant human cancer cell lines.
Ohe Y; Nakagawa K; Fujiwara Y; Sasaki Y; Minato K; Bungo M; Niimi S; Horichi N; Fukuda M; Saijo N
Cancer Res; 1989 Aug; 49(15):4098-102. PubMed ID: 2472873
[TBL] [Abstract][Full Text] [Related]
7. Differential scanning calorimetry of nuclei as a test for the effects of anticancer drugs on human chromatin.
Almagor M; Cole RD
Cancer Res; 1989 Oct; 49(20):5561-6. PubMed ID: 2477145
[TBL] [Abstract][Full Text] [Related]
8. Antitumor activity of a novel antitumor antibiotic, quinocarmycin citrate (KW2152).
Fujimoto K; Oka T; Morimoto M
Cancer Res; 1987 Mar; 47(6):1516-22. PubMed ID: 2434218
[TBL] [Abstract][Full Text] [Related]
9. Effect of human fibroblast interferon on the antiviral activity of mammalian cells treated with bleomycin, vincristine, or mitomycin C.
Suhadolnik RJ; Sawada Y; Flick MB; Reichenbach NL; Mosca JD
Cancer Res; 1983 Nov; 43(11):5462-6. PubMed ID: 6193871
[TBL] [Abstract][Full Text] [Related]
10. Mechanism of action of bisimidazoacridones, new drugs with potent, selective activity against colon cancer.
Hernandez L; Cholody WM; Hudson EA; Resau JH; Pauly G; Michejda CJ
Cancer Res; 1995 Jun; 55(11):2338-45. PubMed ID: 7757985
[TBL] [Abstract][Full Text] [Related]
11. [Enhancement of the effects of anticancer agents on B16 melanoma cells by combination with cepharanthine--II. Antimetabolite, alkylating agent, nitrosourea].
Kubota R; Kubota K; Yamada S
Gan To Kagaku Ryoho; 1992 Nov; 19(13):2169-74. PubMed ID: 1444482
[TBL] [Abstract][Full Text] [Related]
12. Production of protein-associated DNA breaks by 10-[diethylaminopropylamino]-6-methyl-5H-pyrido[3',4':4,5]pyrrolo [2,3-g]isoquinoline in cultured L1210 cells and in isolated nuclei: comparison with other topoisomerase II inhibitors.
Pierson V; Pierre A; Pommier Y; Gros P
Cancer Res; 1988 Mar; 48(6):1404-9. PubMed ID: 2830964
[TBL] [Abstract][Full Text] [Related]
13. Characteristics of antitumor activity of KW-2189, a novel water-soluble derivative of duocarmycin, against murine and human tumors.
Kobayashi E; Okamoto A; Asada M; Okabe M; Nagamura S; Asai A; Saito H; Gomi K; Hirata T
Cancer Res; 1994 May; 54(9):2404-10. PubMed ID: 8162588
[TBL] [Abstract][Full Text] [Related]
14. [A model for the sensitivity determination of anticancer agents against human cancer using nude mice].
Kondo T; Imaizumi M; Taguchi T; Abe O; Hattori T; Wakui A; Kitano M
Gan To Kagaku Ryoho; 1987 Mar; 14(3 Pt 1):680-6. PubMed ID: 3103538
[TBL] [Abstract][Full Text] [Related]
15. Cytotoxicity, DNA strand breakage and DNA-protein crosslinking by a novel transplatinum compound in human A2780 ovarian and MCF-7 breast carcinoma cells.
Farrell N; Povirk LF; Dange Y; DeMasters G; Gupta MS; Kohlhagen G; Khan QA; Pommier Y; Gewirtz DA
Biochem Pharmacol; 2004 Sep; 68(5):857-66. PubMed ID: 15294448
[TBL] [Abstract][Full Text] [Related]
16. Cytotoxicity of antitumor agents toward cultured murine leukemia L1210 cells under a serum-deprived apoptotic condition.
Kasamatsu T; Kohda K; Kawazoe Y
Anticancer Res; 1995; 15(6B):2597-600. PubMed ID: 8669831
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological and toxicological aspects of new imidazoacridinone antitumor agents.
Berger B; Marquardt H; Westendorf J
Cancer Res; 1996 May; 56(9):2094-104. PubMed ID: 8616856
[TBL] [Abstract][Full Text] [Related]
18. [Action mechanisms of zinostatin stimalamer (YM881)].
Tanaka S; Numasaki Y; Maeda H
Gan To Kagaku Ryoho; 1991 Oct; 18(13):2295-300. PubMed ID: 1834022
[TBL] [Abstract][Full Text] [Related]
19. Changes in cyclins and cyclin-dependent kinases induced by DNA damaging agents in a human ovarian cancer cell line expressing mutated or wild-type P53.
Vikhanskaya F; Erba E; D'Incalci M; Broggini M
Exp Cell Res; 1996 Sep; 227(2):380-5. PubMed ID: 8831577
[TBL] [Abstract][Full Text] [Related]
20. Induction of protein-DNA complexes in HeLa S3 cells by KW-2149, a new derivative of mitomycin C.
Fujii N; Arai H; Saito H; Kasai M; Nakano H
Cancer Res; 1993 Oct; 53(19):4466-8. PubMed ID: 8402614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
